![Molecules | Free Full-Text | C-11, a New Antiepileptic Drug Candidate: Evaluation of the Physicochemical Properties and Impact on the Protective Action of Selected Antiepileptic Drugs in the Mouse Maximal Electroshock-Induced Seizure Molecules | Free Full-Text | C-11, a New Antiepileptic Drug Candidate: Evaluation of the Physicochemical Properties and Impact on the Protective Action of Selected Antiepileptic Drugs in the Mouse Maximal Electroshock-Induced Seizure](https://www.mdpi.com/molecules/molecules-26-03144/article_deploy/html/images/molecules-26-03144-g001-550.jpg)
Molecules | Free Full-Text | C-11, a New Antiepileptic Drug Candidate: Evaluation of the Physicochemical Properties and Impact on the Protective Action of Selected Antiepileptic Drugs in the Mouse Maximal Electroshock-Induced Seizure
AI is examining 170,000 potential COVID-19 treatments, Vitamin D is one of only 6 found – Sept 4, 2020 | VitaminDWiki
![WO2016017993A1 - Pharmaceutical formulation comprising amorphous or thermodynamically metastable rivaroxaban - Google Patents WO2016017993A1 - Pharmaceutical formulation comprising amorphous or thermodynamically metastable rivaroxaban - Google Patents](https://patentimages.storage.googleapis.com/0f/c3/5d/4b71a96e7d171d/PCTKR2015007667-appb-I000001.png)
WO2016017993A1 - Pharmaceutical formulation comprising amorphous or thermodynamically metastable rivaroxaban - Google Patents
![عبدالله خربوش on Twitter: "COMPASS trial: Rivaroxaban with or without aspirin in stable CVD. The NEJM. 2017. epub 2017-08-27:1-12. Further evidence of increased major bleeding with this approach will necessitate careful consideration عبدالله خربوش on Twitter: "COMPASS trial: Rivaroxaban with or without aspirin in stable CVD. The NEJM. 2017. epub 2017-08-27:1-12. Further evidence of increased major bleeding with this approach will necessitate careful consideration](https://pbs.twimg.com/media/DpqFVGpW0AATDDu.jpg)
عبدالله خربوش on Twitter: "COMPASS trial: Rivaroxaban with or without aspirin in stable CVD. The NEJM. 2017. epub 2017-08-27:1-12. Further evidence of increased major bleeding with this approach will necessitate careful consideration
Chiral Purity Testing of the Drug Substance Rivaroxaban Using Lux® 5 µm Cellulose-1 Chiral Column as per USP Monograph
![Oral, Direct Factor Xa Inhibitors in Development for the Prevention and Treatment of Thromboembolic Diseases | Arteriosclerosis, Thrombosis, and Vascular Biology Oral, Direct Factor Xa Inhibitors in Development for the Prevention and Treatment of Thromboembolic Diseases | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/585a04a4-457a-4d86-93ee-9b64e0f03b02/5ff1.jpg)